Miroslav Vána, Koray Fidan, Annalisa Berzigotti, Naomi F Lange
{"title":"[非酒精性脂肪肝：新名字，但挑战依然存在]。","authors":"Miroslav Vána, Koray Fidan, Annalisa Berzigotti, Naomi F Lange","doi":"10.23785/PRAXIS.2025.01.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Due to widespread diseases with increasing numbers of patients, such as metabolic syndrome, metabolic liver diseases are becoming the most common liver diseases of the future. The article explains key changes, including the nomenclature change from non-alcoholic fatty liver disease to metabolic dysfunction-associated steatotic liver disease.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 1","pages":"18-22"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Non-alcoholic fatty liver: New name, but the challenge remains].\",\"authors\":\"Miroslav Vána, Koray Fidan, Annalisa Berzigotti, Naomi F Lange\",\"doi\":\"10.23785/PRAXIS.2025.01.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Due to widespread diseases with increasing numbers of patients, such as metabolic syndrome, metabolic liver diseases are becoming the most common liver diseases of the future. The article explains key changes, including the nomenclature change from non-alcoholic fatty liver disease to metabolic dysfunction-associated steatotic liver disease.</p>\",\"PeriodicalId\":20494,\"journal\":{\"name\":\"Praxis\",\"volume\":\"114 1\",\"pages\":\"18-22\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Praxis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23785/PRAXIS.2025.01.005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Praxis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23785/PRAXIS.2025.01.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
[Non-alcoholic fatty liver: New name, but the challenge remains].
Introduction: Due to widespread diseases with increasing numbers of patients, such as metabolic syndrome, metabolic liver diseases are becoming the most common liver diseases of the future. The article explains key changes, including the nomenclature change from non-alcoholic fatty liver disease to metabolic dysfunction-associated steatotic liver disease.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
